200 related articles for article (PubMed ID: 38603884)
1. Mechanical stress induced mitochondrial dysfunction in cardiovascular diseases: Novel mechanisms and therapeutic targets.
Ren H; Hu W; Jiang T; Yao Q; Qi Y; Huang K
Biomed Pharmacother; 2024 May; 174():116545. PubMed ID: 38603884
[TBL] [Abstract][Full Text] [Related]
2. p53 contributes to cardiovascular diseases via mitochondria dysfunction: A new paradigm.
Wang H; Yu W; Wang Y; Wu R; Dai Y; Deng Y; Wang S; Yuan J; Tan R
Free Radic Biol Med; 2023 Nov; 208():846-858. PubMed ID: 37776918
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Proton Leak Plays a Critical Role in Pathogenesis of Cardiovascular Diseases.
Cheng J; Nanayakkara G; Shao Y; Cueto R; Wang L; Yang WY; Tian Y; Wang H; Yang X
Adv Exp Med Biol; 2017; 982():359-370. PubMed ID: 28551798
[TBL] [Abstract][Full Text] [Related]
4. A Mitochondrial Approach to Cardiovascular Risk and Disease.
Veloso CD; Belew GD; Ferreira LL; Grilo LF; Jones JG; Portincasa P; Sardão VA; Oliveira PJ
Curr Pharm Des; 2019; 25(29):3175-3194. PubMed ID: 31470786
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases.
Liu Y; Huang Y; Xu C; An P; Luo Y; Jiao L; Luo J; Li Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555691
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Todisco S; Musio B; Pesce V; Cavalluzzi MM; Petrosillo G; La Piana G; Sgobba MN; Schlosserová N; Cafferati Beltrame L; Di Lorenzo R; Tragni V; Marzulli D; Guerra L; De Grassi A; Gallo V; Volpicella M; Palese LL; Lentini G; Pierri CL
Biochem Pharmacol; 2023 Feb; 208():115405. PubMed ID: 36603686
[TBL] [Abstract][Full Text] [Related]
7. SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.
Divya KP; Kanwar N; Anuranjana PV; Kumar G; Beegum F; George KT; Kumar N; Nandakumar K; Kanwal A
Cardiovasc Toxicol; 2024 Jun; 24(6):598-621. PubMed ID: 38689163
[TBL] [Abstract][Full Text] [Related]
8. Targeting the mitochondrial Ca
Lozano O; Marcos P; Salazar-Ramirez FJ; Lázaro-Alfaro AF; Sobrevia L; García-Rivas G
Acta Physiol (Oxf); 2023 Apr; 237(4):e13946. PubMed ID: 36751976
[TBL] [Abstract][Full Text] [Related]
9. Shear stress augments mitochondrial ATP generation that triggers ATP release and Ca
Yamamoto K; Imamura H; Ando J
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1477-H1485. PubMed ID: 30141983
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases.
Luan Y; Ren KD; Luan Y; Chen X; Yang Y
Front Cardiovasc Med; 2021; 8():770574. PubMed ID: 34938787
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial calcium and reactive oxygen species in cardiovascular disease.
Murphy E; Liu JC
Cardiovasc Res; 2023 May; 119(5):1105-1116. PubMed ID: 35986915
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases.
Shaito A; Aramouni K; Assaf R; Parenti A; Orekhov A; Yazbi AE; Pintus G; Eid AH
Front Biosci (Landmark Ed); 2022 Mar; 27(3):105. PubMed ID: 35345337
[TBL] [Abstract][Full Text] [Related]
13. Natural Products as Modulators of Mitochondrial Dysfunctions Associated with Cardiovascular Diseases: Advances and Opportunities.
Boeing T; Reis Lívero FAD; de Souza P; de Almeida DAT; Donadel G; Lourenço ELB; Gasparotto Junior A
J Med Food; 2023 May; 26(5):279-298. PubMed ID: 37186894
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment.
Yang J; Guo Q; Feng X; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():841523. PubMed ID: 35646910
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells.
Li X; Fang P; Yang WY; Chan K; Lavallee M; Xu K; Gao T; Wang H; Yang X
Can J Physiol Pharmacol; 2017 Mar; 95(3):247-252. PubMed ID: 27925481
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway Orchestrates Mitochondrial Quality Control: A Novel Focus on Cardiovascular Diseases.
Tan Y; Lei C; Tang H; Zhu X; Yi G
DNA Cell Biol; 2020 Sep; 39(9):1494-1505. PubMed ID: 32543894
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases.
Beg MA; Huang M; Vick L; Rao KNS; Zhang J; Chen Y
Trends Pharmacol Sci; 2024 Apr; 45(4):290-303. PubMed ID: 38458847
[TBL] [Abstract][Full Text] [Related]
18. Cardiac mitochondria and reactive oxygen species generation.
Chen YR; Zweier JL
Circ Res; 2014 Jan; 114(3):524-37. PubMed ID: 24481843
[TBL] [Abstract][Full Text] [Related]
19. The role of mitochondrial dysfunction in cardiovascular disease: a brief review.
Chistiakov DA; Shkurat TP; Melnichenko AA; Grechko AV; Orekhov AN
Ann Med; 2018 Mar; 50(2):121-127. PubMed ID: 29237304
[TBL] [Abstract][Full Text] [Related]
20. Arterial remodeling: the role of mitochondrial metabolism in vascular smooth muscle cells.
Qin HL; Bao JH; Tang JJ; Xu DY; Shen L
Am J Physiol Cell Physiol; 2023 Jan; 324(1):C183-C192. PubMed ID: 36468843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
